The new injectable device manufacturing facility in Lehigh Valley will produce retatrutide, Lilly’s investigational once-weekly triple hormone receptor agonist.
The agreement establishes dedicated manufacturing capacity and supply chain controls for consumables used in Ori’s automated cell therapy manufacturing platform.
A Swedish government agency awarded Mendus about $100,000 to establish a donor-derived cell manufacturing platform using a technology that stimulates NK cell expansion.
This presentation addresses key considerations for developing and validating ADC-specific analytical methods, including DAR distribution, free payload, conjugational heterogeneity, product-related impurities and functional potency.